Prospective randomised placebo-controlled double-blind crossover trial in using anti-cholinergics with alpha blockers for the treatment of benign prostatic hyperplasia (BPH) in newly diagnosed patients.
Phase of Trial: Clinical Phase Unknown
Latest Information Update: 02 Jun 2009
At a glance
- Drugs Tamsulosin (Primary) ; Tolterodine (Primary)
- Indications Benign prostatic hyperplasia
- Focus Therapeutic Use
- 08 Aug 2008 New trial record.